332 related articles for article (PubMed ID: 27052576)
1. Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency.
Manco-Johnson MJ; Bomgaars L; Palascak J; Shapiro A; Geil J; Fritsch S; Pavlova BG; Gelmont D
Thromb Haemost; 2016 Jul; 116(1):58-68. PubMed ID: 27052576
[TBL] [Abstract][Full Text] [Related]
2. Protein C deficiency.
Goldenberg NA; Manco-Johnson MJ
Haemophilia; 2008 Nov; 14(6):1214-21. PubMed ID: 19141162
[TBL] [Abstract][Full Text] [Related]
3. Human protein C concentrates for replacement therapy in congenital and acquired protein C deficiency.
Knoebl PN
Drugs Today (Barc); 2008 Jun; 44(6):429-41. PubMed ID: 18596997
[TBL] [Abstract][Full Text] [Related]
4. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
[TBL] [Abstract][Full Text] [Related]
5. Long-term subcutaneous protein C replacement in neonatal severe protein C deficiency.
de Kort EH; Vrancken SL; van Heijst AF; Binkhorst M; Cuppen MP; Brons PP
Pediatrics; 2011 May; 127(5):e1338-42. PubMed ID: 21482600
[TBL] [Abstract][Full Text] [Related]
6. Perioperative management of a patient with purpura fulminans syndrome due to protein C deficiency.
Kumagai K; Nishiwaki K; Sato K; Kitamura H; Yano K; Komatsu T; Shimada Y
Can J Anaesth; 2001 Dec; 48(11):1070-4. PubMed ID: 11744581
[TBL] [Abstract][Full Text] [Related]
7. Paediatric presentation and outcome of congenital protein C deficiency in Japan.
Ohga S; Kang D; Kinjo T; Ochiai M; Doi T; Ishimura M; Kayamori Y; Urata M; Yamamoto J; Suenobu SI; Kanegane H; Ikenoue T; Shirahata A; Hara T
Haemophilia; 2013 May; 19(3):378-84. PubMed ID: 23379934
[TBL] [Abstract][Full Text] [Related]
8. Human protein C concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients.
Veldman A; Fischer D; Wong FY; Kreuz W; Sasse M; Eberspächer B; Mansmann U; Schosser R
Crit Care; 2010; 14(4):R156. PubMed ID: 20723255
[TBL] [Abstract][Full Text] [Related]
9. Purpura fulminans: recognition, diagnosis and management.
Chalmers E; Cooper P; Forman K; Grimley C; Khair K; Minford A; Morgan M; Mumford AD
Arch Dis Child; 2011 Nov; 96(11):1066-71. PubMed ID: 21233082
[TBL] [Abstract][Full Text] [Related]
10. Use of protein C concentrate in neonatal period.
De Carolis MP
Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):29-30. PubMed ID: 21089715
[TBL] [Abstract][Full Text] [Related]
11. [Neonatal purpura fulminans without sepsis due to a severe congenital protein C deficiency].
Hmami F; Cherrabi H; Oulmaati A; Bouabdallah Y; Bouharrou A
Arch Pediatr; 2015 Oct; 22(10):1027-31. PubMed ID: 26228809
[TBL] [Abstract][Full Text] [Related]
12. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency.
Dreyfus M; Masterson M; David M; Rivard GE; Müller FM; Kreuz W; Beeg T; Minford A; Allgrove J; Cohen JD
Semin Thromb Hemost; 1995; 21(4):371-81. PubMed ID: 8747700
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic features of Chinese pediatric patients with severe congenital protein C deficiency who first presented with purpura fulminans: A case series study and literature review.
Tang X; Zhang Z; Yang H; Xiao J; Wen X; Dou Y; Yu J; Hu Y
Thromb Res; 2022 Feb; 210():70-77. PubMed ID: 35026611
[TBL] [Abstract][Full Text] [Related]
14. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.
White B; Livingstone W; Murphy C; Hodgson A; Rafferty M; Smith OP
Blood; 2000 Dec; 96(12):3719-24. PubMed ID: 11090052
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency.
Manco-Johnson MJ; Knapp-Clevenger R
J Pediatr Hematol Oncol; 2004 Jan; 26(1):25-7. PubMed ID: 14707707
[TBL] [Abstract][Full Text] [Related]
16. Acquired Versus Congenital Neonatal Purpura Fulminans: A Case Report and Literature Review.
Findley T; Patel M; Chapman J; Brown D; Duncan AF
J Pediatr Hematol Oncol; 2018 Nov; 40(8):625-627. PubMed ID: 29683961
[TBL] [Abstract][Full Text] [Related]
17. Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis.
Colling ME; Bendapudi PK
Transfus Med Rev; 2018 Apr; 32(2):69-76. PubMed ID: 29157918
[TBL] [Abstract][Full Text] [Related]
18. Treatment of purpura fulminans in meningococcemia with protein C concentrate.
Rivard GE; David M; Farrell C; Schwarz HP
J Pediatr; 1995 Apr; 126(4):646-52. PubMed ID: 7699550
[TBL] [Abstract][Full Text] [Related]
19. Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study.
Limperger V; Klostermeier UC; Kenet G; Holzhauer S; Alhenc Gelas M; Finckh U; Junker R; Heller C; Zieger B; Kurnik K; Knöfler R; Mesters R; Halimeh S; Nowak-Göttl U
Br J Haematol; 2014 Nov; 167(3):385-93. PubMed ID: 25039884
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C concentrate treatment for skin necrosis under warfarin treatment in severe genetic protein C deficiency combined with prothrombin mutation and factor V Leiden.
Rosenzweig N; Strauss T; Rubinstein M; Paret G; Kenet G
Thromb Haemost; 2009 Feb; 101(2):405-7. PubMed ID: 19190829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
